Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
CardioGenics Holdings Inc | 100.0 | 0.0x | --- |
Paradigm Medical Industries Inc | 3.3K | 0.0x | --- |
Nemaura Medical Inc | 40.0 | 0.0x | --- |
Coded Growth Innovation Center Inc | 60.0 | --- | --- |
SurgLine International Inc | 5.7K | --- | --- |
Home Solutions Health Inc | 250.0 | 0.0x | --- |
CardioGenics Holdings Inc. is focused on technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. The Company has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improves instrument sensitivity to light.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $100.00 |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 96.1M |
CardioGenics Holdings Inc does not pay a dividend. | |
Beta | 1.44 |
EPS | $-0.01 |
Book Value | $-0.01 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.